ctrl K

Watchlist Price Alert

Neuphoria Therapeutics In... (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

6.65

-0.05 (-0.75%)

At close: Jun 17, 2025, 1:48 PM

Neuphoria Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Revenue	15.66M	662.72K	n/a	n/a	n/a	n/a
Cost of Revenue	331.13K	165.7K	165.7K	165.7K	n/a	n/a
Gross Profit	15.33M	496.71K	-166K	-166K	n/a	n/a
Operating Income	2.31M	-14.22M	-15.98M	-12.41M	-10.02M	-5.47M
Interest Income	132.07K	174.04K	229.87K	193.77K	141.16K	86.44K
Pretax Income	5.55M	-10.22M	-13.8M	-12.86M	-10.1M	-5.51M
Net Income	5.74M	-10.08M	-13.61M	-12.8M	-10.03M	-5.47M
Selling & General & Admin	6.57M	7.84M	7.59M	5.93M	4.9M	2.38M
Research & Development	6.45M	6.87M	8.22M	6.32M	5.12M	3.09M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	13.02M	14.72M	15.82M	12.25M	10.02M	5.47M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.52M	10.09M	11.19M	7.63M	10.02M	5.47M
Income Tax Expense	-185.19K	-138.8K	-185.2K	-53.2K	-69.59K	-34.79K
Shares Outstanding (Basic)	234.01M	234.01M	234.01M	143.52M	137.23M	124.67M
Shares Outstanding (Diluted)	234.01M	234.01M	234.01M	143.52M	137.23M	124.67M
EPS (Basic)	0.02	-0.06	-0.1	-0.1	-0.08	-0.04
EPS (Diluted)	0.02	-0.06	-0.1	-0.1	-0.08	-0.04
EBITDA	4.75M	-10.89M	-12.96M	-12.19M	-9.59M	-5.3M
EBIT	4.08M	-11.55M	-13.62M	-12.69M	-9.93M	-5.47M
Depreciation & Amortization	662.97K	663.23K	663.02K	497.31K	331.6K	165.91K